Analysis of Biomarkers and Marginal Bone Loss in Platform‐Switched and Nonplatform‐Switched Implants: A Randomized Clinical Trial

Abstract

PS was superior to NPS regarding the preservation of MBL. Higher MCP-1 levels, altered RANKL/OPG ratio, and lower OPG levels in the NPS group could be associated with subclinical peri-implant bone remodeling.